Business
A LETTER TO PACIRA BIOSCIENCES SHAREHOLDERS FROM DOMA PERPETUAL CAPITAL MANAGEMENT LLC
DOMA Perpetual Capital Management ("DOMA Perpetual"), which, together with its affiliates (collectively, "DOMA" or "we"), beneficially owns approximately 7.5% of the outstanding shares of common stock of Pacira BioSciences, Inc. (NASDAQ: PCRX) ("Pacira" or the "Company"), has today sent a letter to the Company's stockholders.
About this update from Pacira Biosciences, Inc.
[{"type":"text","content":"FRANK LEE AND THE BOARD HAVE OVERSEEN GROSS AND PERSISTENT UNDERPERFORMANCE FOR YEARS. WHY WOULD SHAREHOLDERS VOTE TO CONTINUE THIS UNRELENTING LACK OF TOTAL RETURN TO SHAREHOLDERS ("TRS"), WHILE ALLOWING MANAGEMENT AND THE BOARD TO FURTHER ENRICH THEMSELVES WITH TENS OF MILLIONS OF DOLLARS IN PAYOUTS?","length":313,"tagName":"p","attribs":{}},{"type":"text","content":"EXPAREL IS THE COMPANY'S CORE ASSET; WE BELIEVE BOARD MISMANAGEMENT OF THE PATENT RISK AMOUNTS TO GROSS NEGLIGENCE AND A FAILURE OF THE DUTY OF CARE","length":152,"tagName":"p","attribs":{}},{"type":"text","content":"SHAREHOLDERS SHOULD DECIDE IF THE SALE PRICE THE COMPANY FINDS THROUGH A DISCIPLINED, BOARD‑SUPERVISED PROCESS IS ADEQUATE AND IN THE BEST INTERESTS OF ALL SHAREHOLDERS","length":168,"tagName":"p","attribs":{}},{"type":"text","content":"MIAMI, May 21, 2026 /PRNewswire/ -- DOMA Perpetual Capital Management ("DOMA Perpetual"), which, together with its affiliates (collectively, "DOMA" or "we"), beneficially owns approximately 7.5% of the outstanding shares of common stock of Pacira BioSciences, Inc. (NASDAQ: PCRX) ("Pacira" or the "Company"), has today sent a letter to the Company's stockholders.","length":417,"tagName":"p"},{"type":"image","alt":"DOMA Perpetual Capital Management LLC (PRNewsfoto/DOMA Perpetual)","displaySize":"","headline":null,"caption":"DOMA Perpetual Capital Management LLC (PRNewsfoto/DOMA Perpetual)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":118,"url":"https://media.zenfs.com/en/prnewswire.com/1e8ded2293e965ad361d9ce30d6866e3"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/NgKCrMfj16DkteLv.vpYsA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTIwOA--/https://media.zenfs.com/en/prnewswire.com/1e8ded2293e965ad361d9ce30d6866e3","width":400,"height":118},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/M5.Yxu79WNVQQZU3S_9XEQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTE4OQ--/https://media.zenfs.com/en/prnewswire.com/1e8ded2293e965ad361d9ce30d6866e3","width":400,"height":118}},"href":"https://mma.prnewswire.com/media/2468496/DOMA_Perpetual_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"In its letter, DOMA Perpetual asserts Frank Lee and the Board have grossly underperformed for years and years, with no end in si...